Zdrowie i gospodarka · 09/02/2001

FDA Announces Collection of Information for OMB Review

The Food and Drug Administration (FDA) is announcing that it has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, which will impact the registration of drug producers and listing of drugs in commercial distribution.